Rate My Professor Samira Bell

Dr Samira Bell is a Clinical Reader within the Division of Population Health and Genomics in the School of Medicine at the University of Dundee, holding the position alongside her role as Honorary Consultant Nephrologist at Ninewells Hospital, NHS Tayside. She obtained her medical degree (MBChB) in 1999 and her Doctor of Medicine (MD) in 2007, both from the University of Glasgow. After completing her renal training in the West of Scotland, she was appointed as Consultant Nephrologist at Ninewells Hospital in 2009. She remained a full-time NHS consultant until 2019, at which point she was appointed Senior Clinical Lecturer at the University of Dundee, progressing to Clinical Reader in her current role.

Dr Bell's academic interests focus on the use of healthcare data to improve outcomes for people living with kidney disease. Her research specializations encompass acute kidney injury, clinical nephrology, and renal epidemiology. She leads investigations into pain in chronic kidney disease, integrating clinical and experimental medicine, genetic epidemiology, and pharmacoepidemiology. Dr Bell holds several prominent leadership positions, including Associate Director of the BHF Data Science Centre Kidney Catalyst at HDR UK, Lead for the NHS Research Scotland Renal Research Network, Co-chair of the UK Renal Health Data Network, and Associate Postgraduate Dean for Academic Training at NHS Education for Scotland. Her key publications include 'Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery' (BMJ, 2015), 'Postoperative AKI—Prevention Is Better than Cure?' (Journal of the American Society of Nephrology, 2019), 'Harmonization of epidemiology of acute kidney injury and acute kidney disease' (Kidney International, 2022), 'Patient outcomes following AKI and AKD: a population-based cohort study' (BMC Medicine, 2022), 'The prevalence of pain among patients with chronic kidney disease' (Kidney International, 2021), 'Deprivation and limitations in daily life in new onset kidney disease: a population study' (2026), and 'Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis' (British Journal of Cancer, 2025).